Hormone cosmetics

FDA withdraws advanced notice of proposed rulemaking for cosmetic products containing certain hormone ingredients effective Nov. 26, as it is no longer considered a viable candidate for further action, the agency reports in a 1Federal Register notice published last year and recently posted on dockets. Action is part of a move to reduce FDA's regulatory backlog. Agency received nine comments relating to the withdrawal of the hormone-containing cosmetics ANPR, some of which argued the move could call into question points raised in the proposed rule and change the marketing status of these products. FDA responds the withdrawal neither affirms nor rejects statements in the preamble, and as the proposed rule, published in 1993 permitting progesterone and pregnenolone in cosmetics in certain concentrations, was never finalized, its withdrawal does not change the marketing status of these products. Agency announced its intention to withdraw the proposed ANPR along with 83 other proposed actions in 2003 (2"The Rose Sheet" April 3, 2003, p. 10)...